| Literature DB >> 19949358 |
Vassiliki Papaevangelou1, Marianna Varsami, Vassilios Papadakis, Aglaia Zellos, Agapi Parcharidou, Sophia Papargyri, Ourania Karentzou, Nina Manolaki, Eleftheria Roma, Sophia Polychronopoulou.
Abstract
In patients with malignancies, chronic hepatitis C reactivation or severe flare is uncommon and antiviral treatment is deferred mainly due to underlying bone marrow and immune suppression. We report the use of antiviral treatment concomitantly to chemotherapy in 3 children with hematologic malignancies, chronic hepatitis C, and significant liver dysfunction.Entities:
Mesh：
Substances：
Year: 2010 PMID： 19949358 DOI： 10.1097/INF.0b013e3181c2115a
Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129